Medications starting with
Poland-
The medicine is used in elderly people to prevent and treat calcium and vitamin D deficiency. It is also used as an adjunct to osteoporosis treatment in patients at high risk of these deficiencies.
Dosage form: tablets, film-coated
Active substance Dosage calcium carbonate 1500 mg cholecalciferol 4 mg ATC code: A12AX
Manufacturer: Beres Pharmaceuticals Ltd.
-
The medicine is used in pregnant women to stop nausea and vomiting, if dietary changes or other non-medicinal methods have not yielded results.
Dosage form: tablets, modified release
Active substance Dosage doxylamine succinate 20 mg pyridoxine hydrochloride 20 mg ATC code: R06AA59
Manufacturer: Laboratorios Liconsa S.A.
-
The medicine is used in pregnant women to control nausea and vomiting, if dietary changes or other non-medicinal methods have not yielded results.
Dosage form: tablets, modified release
Active substance Dosage doxylamine hydrogen succinate 20 mg pyridoxine hydrochloride 20 mg ATC code: R06AA59
Manufacturer: Exeltis Healthcare S.L.
-
The medicine is used for the treatment of schizophrenia, mania, and depression occurring in bipolar disorder.
Dosage form: tablets, film-coated
Active substance Dosage quetiapine 25 mg ATC code: N05AH04
Manufacturer: Genepharm S.A. PharmaPath S.A.
-
The medicine is used in the treatment of schizophrenia, mania, and depression occurring in bipolar disorder.
Dosage form: tablets, film-coated
Active substance Dosage quetiapine 100 mg ATC code: N05AH04
Manufacturer: Genepharm S.A.
-
The medicine is used in the treatment of schizophrenia, mania, and depression occurring in the course of bipolar disorder.
Dosage form: tablets, film-coated
Active substance Dosage quetiapine 200 mg ATC code: N05AH04
Manufacturer: Genepharm S.A.
-
The medicine is used in the treatment of schizophrenia, mania, and depression occurring in bipolar disorder.
Dosage form: tablets, film-coated
Active substance Dosage quetiapine 300 mg ATC code: N05AH04
Manufacturer: Genepharm S.A.
-
The medicine is used in the treatment of depression (in the course of bipolar affective disorder or major depressive disorder), mania, and schizophrenia.
Dosage form: tablets, prolonged release
Active substance Dosage quetiapine 200 mg ATC code: N05AH04
Manufacturer: Pharmathen International S.A.
-
The medicine is used in the treatment of depression in bipolar disorder, major depressive episodes, mania, and schizophrenia.
Dosage form: tablets, prolonged release
Active substance Dosage quetiapine 300 mg ATC code: N05AH04
Manufacturer: Pharmathen International S.A.
-
The medicine is used in the treatment of depression in bipolar disorder, major depressive episodes, mania, and schizophrenia.
Dosage form: tablets, prolonged release
Active substance Dosage quetiapine 400 mg ATC code: N05AH04
Manufacturer: Pharmathen International S.A.
-
The vaccine is used to prevent diphtheria, tetanus, and pertussis (whooping cough). It helps the body develop its own immunity to these three diseases.
Dosage form: solution for injection in ampoule-syringe
Active substance Dosage diphtheria toxoid No input provided tetanus toxoid No input provided bordetella pertussis antigens No input provided ATC code: J07AJ52
Manufacturer: GlaxoSmithKline Biologicals S.A.
-
The vaccine is used to prevent diphtheria, tetanus, pertussis (whooping cough), and poliomyelitis (polio). It helps the body develop immunity to these four diseases.
Dosage form: solution for injection in ampoule-syringe
Active substance Dosage diphtheria toxoid > or equal to 2 IU (2.5 Lf) aluminum phosphate 0.2 mg Al 3+ inactivated poliovirus type 1 40 units of antigen D inactivated poliovirus type 2 8 units of antigen D inactivated poliovirus type 3 32 units of antigen D tetanus toxoid > or equal 20 IU (5 Lf) aluminum hydroxide hydrate 0.3 mg Al 3+ bordetella pertussis antigens 8 mcg + 8 mcg + 2.5 mcg ATC code: J07CA02
Manufacturer: GlaxoSmithKline Biologicals S.A.
-
The medicine is used for the treatment of pulmonary arterial hypertension (PAH) to improve exercise capacity and relieve symptoms, as well as for the treatment of digital tip ulcers in adult patients with systemic sclerosis.
Dosage form: tablets, film-coated
Active substance Dosage bosentan 62.5 mg ATC code: C02KX01
Manufacturer: ITC Farma S.r.l.
-
It is used in the treatment of pulmonary arterial hypertension (PAH) to improve physical capacity and relieve symptoms, and in the treatment of digital ulcers in adults with systemic sclerosis.
Dosage form: tablets, film-coated
Active substance Dosage bosentan 125 mg ATC code: C02KX01
Manufacturer: ITC Production S.r.l. S.C. Zentiva S.A. Zentiva, k.s.
-
It is used for disinfection in cases of skin inflammation, eczema, burns, bruises, soft tissue swelling, superficial epidermal or skin damage, and in inflammatory conditions of the external genitalia.
Dosage form: solution, topical
Active substance Dosage boric acid 3 g ATC code: D08AD
Manufacturer: Poznan Herbal Plants Factory "Herbapol" S.A.
-
It is used in the treatment of high blood pressure (hypertension), angina pectoris (chest tightness), and heart failure.
Dosage form: tablets, film-coated
Active substance Dosage bisoprolol fumarate 5 mg ATC code: C07AB07
Manufacturer: Alkaloid - INT d.o.o.
-
The medicine is used to treat heart failure, which is characterized by shortness of breath during physical exertion or fluid retention in the body. It may be used as an add-on treatment in combination with other medicines.
Dosage form: tablets, film-coated
Active substance Dosage bisoprolol fumarate 2.5 mg ATC code: C07AB07
Manufacturer: Alkaloid - INT d.o.o.
-
It is used in the treatment of high blood pressure (hypertension), angina pectoris (chest tightness), and heart failure.
Dosage form: tablets, film-coated
Active substance Dosage bisoprolol fumarate 10 mg ATC code: C07AB07
Manufacturer: Alkaloid - INT d.o.o.
-
The medicinal product is used in the treatment of multiple myeloma (a type of bone marrow cancer) in adults over 18 years of age and in the treatment of mantle cell lymphoma (a type of cancer affecting the lymph nodes).
Dosage form: powder for preparation of injection solution
Active substance Dosage bortezomib 1 mg ATC code: L01XX32
Manufacturer: Adamed Pharma S.A., Synhon s.r.o., Synthon Hispania S.L.
-
The medicinal product is used to treat multiple myeloma (a type of bone marrow cancer) in adults over 18 years of age and to treat mantle cell lymphoma (a type of cancer that affects the lymph nodes) in individuals at least 18 years old.
Dosage form: powder for preparation of injection solution
Active substance Dosage bortezomib 3.5 mg ATC code: L01XX32
Manufacturer: Adamed Pharma S.A. Synthon Hispania S.L. Synthon s.r.o.
-
The medicine is used to treat multiple myeloma (a type of bone marrow cancer) in adults and to treat mantle cell lymphoma (a type of cancer that affects the lymph nodes).
Dosage form: powder for preparation of injection solution
Active substance Dosage bortezomib 2.5 mg ATC code: L01XX32
Manufacturer: Adamed Pharma S.A. Synthon Hispania S.L. Synthon s.r.o.
-
The medicinal product is used to treat multiple myeloma (a type of bone marrow cancer) in adults and to treat mantle cell lymphoma (a type of cancer that affects the lymph nodes).
Dosage form: powder for preparation of injection solution
Active substance Dosage bortezomib 3.5 mg ATC code: L01XG01
Manufacturer: APL Swift Services (Malta) Ltd. Arrow Generiques Generis Farmacêutica, S.A.
-
The medicinal product is used in the treatment of multiple myeloma (a type of bone marrow cancer) in adults and in the treatment of mantle cell lymphoma (a type of cancer affecting the lymph nodes).
Dosage form: solution for injection
Active substance Dosage bortezomib 2.5 mg/ml ATC code: L01XG01
Manufacturer: EVER Pharma Jena GmbH
-
The medicinal product is used to treat multiple myeloma (a type of bone marrow cancer) and mantle cell lymphoma (a type of lymph node cancer) in patients over 18 years of age.
Dosage form: powder for preparation of injection solution
Active substance Dosage bortezomib 3.5 mg ATC code: L01XG01
Manufacturer: Synthon Hispania S.L. Synthon s.r.o.
-
The medicinal product is used in the treatment of multiple myeloma (a type of bone marrow cancer) in adults over 18 years of age and in the treatment of mantle cell lymphoma (a type of lymph node cancer).
Dosage form: powder for preparation of injection solution
Active substance Dosage bortezomib 1 mg ATC code: L01XG01
Manufacturer: Synthon Hispania S.L. Synthon s.r.o.
-
This medicine is used to treat multiple myeloma (a type of bone marrow cancer) in adults over 18 years of age and to treat mantle cell lymphoma (a type of cancer that affects the lymph nodes).
Dosage form: powder for preparation of injection solution
Active substance Dosage bortezomib 1 mg ATC code: L01XX32
Manufacturer: Krka, d.d., Novo mesto
-
The medicine is used to treat multiple myeloma (a type of bone marrow cancer) in adults over 18 years of age and to treat mantle cell lymphoma in adults over 18 years of age.
Dosage form: powder for preparation of injection solution
Active substance Dosage bortezomib 3.5 mg ATC code: L01XX32
Manufacturer: Krka, d.d., Novo mesto
-
The medicinal product is used in the treatment of multiple myeloma (a type of bone marrow cancer) in adults and in the treatment of mantle cell lymphoma (a type of cancer that affects the lymph nodes).
Dosage form: powder for preparation of injection solution
Active substance Dosage bortezomib 1 mg ATC code: L01XX32
Manufacturer: Synthon Hispania S.L. Synthon s.r.o.
-
The medicinal product is used in the treatment of multiple myeloma (a type of bone marrow cancer) in adults and in the treatment of mantle cell lymphoma (a type of cancer that affects the lymph nodes).
Dosage form: powder for preparation of injection solution
Active substance Dosage bortezomib 3.5 mg ATC code: L01XX32
Manufacturer: Synthon Hispania S.L. Synthon s.r.o.
-
The medicine is used in the treatment of multiple myeloma (a bone marrow cancer) in adults and in the treatment of mantle cell lymphoma (a type of cancer that affects the lymph nodes).
Dosage form: powder for preparation of injection solution
Active substance Dosage bortezomib 3.5 mg ATC code: L01XX32
Manufacturer: Pharmadox Healthcare Ltd.
-
The medicine is used in adult patients for the treatment of multiple myeloma (a bone marrow cancer) and mantle cell lymphoma (a type of cancer that affects the lymph nodes).
Dosage form: powder for preparation of injection solution
Active substance Dosage bortezomib 3.5 mg ATC code: L01XX32
Manufacturer: Betapharm Arzneimittel GmbH Rual Laboratories SRL
-
The medicinal product is used to treat multiple myeloma (a type of bone marrow cancer) in adults over 18 years of age and to treat mantle cell lymphoma (a type of cancer that affects the lymph nodes).
Dosage form: powder for preparation of injection solution
Active substance Dosage bortezomib 3.5 mg ATC code: L01XG01
Manufacturer: PHARMIDEA SIA
-
The medicinal product is used to treat multiple myeloma (a type of bone marrow cancer) in adults and to treat mantle cell lymphoma (a type of cancer that affects the lymph nodes).
Dosage form: powder for preparation of injection solution
Active substance Dosage bortezomib 3.5 mg ATC code: L01XX32
Manufacturer: Synthon Hispania S.L. Synthon s.r.o.
-
The medicine is used in patients over 18 years of age for the treatment of multiple myeloma (a bone marrow cancer) and mantle cell lymphoma (a type of cancer affecting the lymph nodes).
Dosage form: powder for preparation of injection solution
Active substance Dosage bortezomib 1 mg ATC code: L01XX32
Manufacturer: Synthon Hispania S.L. Synthon s.r.o.
-
The medicine is used to treat pulmonary arterial hypertension (PAH) to improve exercise capacity and relieve symptoms, and to treat digital ulcers in adults with systemic sclerosis.
Dosage form: tablets, film-coated
Active substance Dosage bosentan monohydrate 129.083 mg ATC code: C02KX01
Manufacturer: Alkaloida Pharmaceutical Manufacturing Ltd., Sun Pharmaceutical Industries Europe B.V., Terapia S.A.
-
The medicine is used to treat pulmonary arterial hypertension (PAH) to dilate the blood vessels in the lungs, which makes it easier for the heart to pump blood and improves physical capacity. It is also used to reduce the number of new finger tip ulcers in adults with systemic sclerosis.
Dosage form: tablets, film-coated
Active substance Dosage bosentan 125 mg ATC code: C02KX01
Manufacturer: Lek Pharmaceuticals d.d. Salutas Pharma GmbH
-
The medicine is used in adults and children and adolescents (over 6 years of age) suffering from Ph-positive chronic myeloid leukemia. It is intended for individuals in whom the disease has been newly diagnosed or in whom previous treatment has not been effective.
Dosage form: tablets, film-coated
Active substance Dosage bosutinib 500 mg ATC code: L01EA04
Manufacturer: MSN Labs Europe Limited Pharmadox Healthcare Limited
-
This medicine is used in adults as well as in children and adolescents over 6 years of age with Ph-positive chronic myeloid leukemia. It may be used in newly diagnosed disease or when previous treatment has not been effective. It is also used in patients in the accelerated phase or the blast crisis phase.
Dosage form: tablets, film-coated
Active substance Dosage bosutinib 400 mg ATC code: L01EA04
Manufacturer: MSN Labs Europe Limited Pharmadox Healthcare Limited
-
It is used in adults as well as in children and adolescents over 6 years of age with Ph-positive chronic myeloid leukemia. It may be used in cases of newly diagnosed disease or when previous treatment has not been effective. The medicine is also used in the accelerated phase and the blast crisis phase of this leukemia.
Dosage form: tablets, film-coated
Active substance Dosage bosutinib 100 mg ATC code: L01EA04
Manufacturer: MSN Labs Europe Limited Pharmadox Healthcare Limited
-
The medicine is intended for adult patients with chronic myeloid leukemia with the presence of the Philadelphia chromosome (Ph-positive type), who have newly diagnosed disease or for whom previous treatment has not been effective or appropriate.
Dosage form: tablets, film-coated
Active substance Dosage bosutinib 100 mg ATC code: L01EA04
Manufacturer: Coripharma ehf.
-
The medicine is intended for adult patients with chronic myeloid leukemia with the presence of the Philadelphia chromosome (Ph-positive type). It is used in cases of newly diagnosed disease or when previous medications have not yielded the expected results.
Dosage form: tablets, film-coated
Active substance Dosage bosutinib 500 mg ATC code: L01EA04
Manufacturer: Coripharma ehf.
-
The medicine is used in adults and children over 6 years of age for the treatment of chronic myeloid leukemia (Ph-positive type) in the newly diagnosed phase, the accelerated phase, or the blast crisis phase, when previous treatment has been ineffective or inappropriate.
Dosage form: tablets, film-coated
Active substance Dosage bosutinib 100 mg ATC code: L01EA04
Manufacturer: Lek Pharmaceuticals d.d., Pharmadox Healthcare Limited, Salutas Pharma GmbH
-
The medicine is used in adults and children over 6 years of age for the treatment of chronic myeloid leukemia (Ph-positive type) in the newly diagnosed phase or in patients for whom previous treatment has not been effective. It is also used in adults in the accelerated phase and the blast crisis phase of this disease.
Dosage form: tablets, film-coated
Active substance Dosage bosutinib 400 mg ATC code: L01EA04
Manufacturer: Lek Pharmaceuticals d.d., Pharmadox Healthcare Limited, Salutas Pharma GmbH
-
The medicine is used in adults and children over 6 years of age for the treatment of chronic myeloid leukemia (Ph-positive type), when the disease has been newly diagnosed or when previous treatments have not been effective. It is also used in adults in the accelerated phase or blast crisis of this disease.
Dosage form: tablets, film-coated
Active substance Dosage bosutinib 500 mg ATC code: L01EA04
Manufacturer: Lek Pharmaceuticals d.d., Pharmadox Healthcare Limited, Salutas Pharma GmbH
-
The medicine is intended for adult patients with Ph-positive chronic myeloid leukemia who have newly diagnosed disease or for whom previous treatment has not been effective.
Dosage form: tablets, film-coated
Active substance Dosage bosutinib 400 mg ATC code: L01EA04
Manufacturer: Clonmel Healthcare Ltd., Coripharma ehf., STADA Arzneimittel AG, Germany
-
The medicine is intended for adult patients with chronic myeloid leukemia with the presence of the Philadelphia chromosome (Ph-positive type), who have newly diagnosed disease or for whom previous treatment has not been effective or appropriate.
Dosage form: tablets, film-coated
Active substance Dosage bosutinib 500 mg ATC code: L01EA04
Manufacturer: Clonmel Healthcare Ltd., Coripharma ehf., STADA Arzneimittel AG, Germany
-
This medicine is used in adult patients with Ph-positive chronic myeloid leukemia, who have newly diagnosed disease or for whom previous treatment has not been effective or has been inappropriate.
Dosage form: tablets, film-coated
Active substance Dosage bosutinib 100 mg ATC code: L01EA04
Manufacturer: Clonmel Healthcare Ltd., Coripharma ehf., STADA Arzneimittel AG, Germany
-
This medicine is used in adult patients with Ph-positive chronic myeloid leukemia, who have newly diagnosed disease or for whom previous treatment has not been effective or has been inappropriate.
Dosage form: tablets, film-coated
Active substance Dosage bosutinib 100 mg ATC code: L01EA04
Manufacturer: Coripharma ehf.
-
The medicine is intended for adult patients with Ph-positive chronic myeloid leukemia. It is used in individuals whose disease has only recently been diagnosed or in those for whom previous treatment has not been effective.
Dosage form: tablets, film-coated
Active substance Dosage bosutinib 500 mg ATC code: L01EA04
Manufacturer: Coripharma ehf.
-
The medicine is intended for adult patients with Ph-positive chronic myeloid leukemia, who have newly diagnosed disease or for whom previous treatment has been ineffective or inappropriate.
Dosage form: tablets, film-coated
Active substance Dosage bosutinib 400 mg ATC code: L01EA04
Manufacturer: Coripharma ehf.